Abbott
ABT
$0.27 (0.20%)
1D
1W
3M
1Y
5Y
ALL
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 3 days ago • ABT
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel HealthierZacks Investment Research • 4 days ago • ABT
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?Zacks Investment Research • 5 days ago • ABT
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?Zacks Investment Research • 7 days ago • ABT
Abbott (ABT) Stock Dips While Market Gains: Key FactsPRNewsWire • 10 days ago • ABT
Abbott Declares 406th Consecutive Quarterly DividendCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.